Zachura Małgorzata, Wilczek Krzysztof, Janion Marianna, Gąsior Mariusz, Gierlotka Marek, Sadowski Marcin
2nd Department of Cardiology.
3rd Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease, Zabrze.
Coron Artery Dis. 2019 May;30(3):171-176. doi: 10.1097/MCA.0000000000000703.
The failure of reperfusion therapy in patients with ST-segment elevation myocardial infarction (STEMI) is more frequent than considered previously.
To evaluate sex-related differences in long-term outcomes in patients with STEMI and incomplete infarct-related artery reperfusion after a primary percutaneous coronary intervention.
Of consecutive 42 752 patients with STEMI hospitalized between 2009 and 2011 in Poland, we analyzed a group of 766 (35%) women and 1453 (65%) men with less than thrombolysis in myocardial infarction (TIMI) flow grade 3 following a primary percutaneous coronary intervention.
In the 2-year follow-up, the mortality rate among women was significantly higher compared with men: 39.8 versus 30.9% (P=0.0009) in the TIMI 0 or 1 group, and 31.6 versus 20% (P<0.0001) in the TIMI 2 group. In women, the risk of rehospitalization because of heart failure was significantly higher irrespective of the final TIMI flow grade. In the multivariate analysis, female sex did not influence both in-hospital (odds ratio: 1.09; 95% confidence interval: 0.82-1.44; P=0.54) and long-term (hazard ratio: 1.14; 95% confidence interval: 0.97-1.34; P=0.11) mortality. Peripheral artery disease, anterior myocardial infarction, and previous stroke were associated with increased mortality only in men. Postprocedural TIMI flow grade 2 (vs. TIMI grade 0 or 1) was the strongest factor impacting mortality irrespective of sex.
Women with STEMI and postprocedural suboptimal epicardial blood flow have higher mortality than men and are at high risk of developing heart failure, with frequent in-patient visits. However, these differences may be attributed to the advanced age and worse clinical presentation of women compared with men.
ST段抬高型心肌梗死(STEMI)患者再灌注治疗失败的情况比之前认为的更为常见。
评估接受直接经皮冠状动脉介入治疗后STEMI且梗死相关动脉再灌注不完全的患者长期预后的性别差异。
在2009年至2011年期间于波兰住院的连续42752例STEMI患者中,我们分析了一组766例(35%)女性和1453例(65%)男性,这些患者在直接经皮冠状动脉介入治疗后心肌梗死溶栓(TIMI)血流分级低于3级。
在2年随访中,女性的死亡率显著高于男性:TIMI 0或1组中分别为39.8%和30.9%(P = 0.0009),TIMI 2组中分别为31.6%和20%(P < 0.0001)。无论最终TIMI血流分级如何,女性因心力衰竭再次住院的风险显著更高。在多变量分析中,女性性别对住院期间(比值比:1.09;95%置信区间:0.82 - 1.44;P = 0.54)和长期(风险比:1.14;95%置信区间:0.97 - 1.34;P = 0.11)死亡率均无影响。外周动脉疾病、前壁心肌梗死和既往中风仅与男性死亡率增加相关。术后TIMI血流分级2级(与TIMI 0或1级相比)是影响死亡率的最强因素,与性别无关。
STEMI且术后心外膜血流未达最佳的女性死亡率高于男性,且发生心力衰竭的风险高,住院就诊频繁。然而,这些差异可能归因于女性与男性相比年龄更大且临床表现更差。